Superpime Injection 1 gm/vial contains Cefepime Hydrochloride, a fourth-generation cephalosporin antibiotic with broad-spectrum activity against both Gram-positive and Gram-negative bacteria. It is widely used in hospitals and clinical settings to treat serious bacterial infections, especially those caused by multi-drug resistant organisms.
Cefepime works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Superpime Injection is suitable for intravenous or intramuscular administration, providing rapid therapeutic levels in the bloodstream for prompt infection control. Its enhanced stability against beta-lactamases makes it effective against strains resistant to earlier-generation cephalosporins.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Superpime Injection 1 gm/vial is indicated for the treatment of:
Severe infections caused by susceptible bacteria, including:
Lower respiratory tract infections (pneumonia, bronchitis)
Urinary tract infections, including complicated UTIs
Skin and soft tissue infections
Intra-abdominal infections
Febrile neutropenia in immunocompromised patients
Septicemia and bacteremia due to susceptible organisms
Empiric therapy for serious infections when resistant pathogens are suspected
It is reserved for serious infections where rapid and effective antibacterial therapy is critical.
Cefepime, the active ingredient in Superpime Injection, is a beta-lactam antibiotic. Its mechanism includes:
Inhibition of bacterial cell wall synthesis: Binds to penicillin-binding proteins (PBPs), preventing cross-linking of peptidoglycan layers
Bactericidal activity: Leads to cell wall destabilization, bacterial lysis, and death
Broad-spectrum efficacy: Active against many Gram-positive and Gram-negative organisms, including Pseudomonas aeruginosa
Stability against beta-lactamases: Remains effective against some resistant strains that inactivate earlier-generation cephalosporins
This mechanism allows Cefepime to treat complicated infections and serious bacterial illnesses effectively.
The usual adult dose is 1–2 grams every 12 hours, administered intravenously (IV) or intramuscularly (IM), depending on the severity and site of infection.
Dosage adjustments may be required in patients with renal impairment.
For severe infections, higher doses may be recommended under strict medical supervision.
The vial should be reconstituted with sterile water or appropriate diluent according to instructions before administration.
Administer slowly IV over 3–5 minutes or via infusion as directed by a healthcare professional.
Use cautiously in patients with allergies to cephalosporins or penicillins, as cross-reactivity may occur.
Monitor renal and hepatic function during prolonged therapy.
May cause diarrhea, including Clostridium difficile-associated diarrhea; report persistent or severe gastrointestinal symptoms.
Use with caution in patients with history of gastrointestinal disease, such as colitis, or in immunocompromised individuals.
Inform the healthcare provider about all other medications being taken to avoid interactions, including aminoglycosides or anticoagulants.
Superpime Injection 1 gm/vial is generally well tolerated. Common side effects may include:
Mild gastrointestinal upset (nausea, diarrhea)
Injection site reactions (pain, redness)
Headache or dizziness
Rare but serious effects: allergic reactions, rash, fever, hematologic abnormalities, or nephrotoxicity
Immediate medical attention is required if severe allergic reactions or signs of superinfection occur.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Store the vials below 30°C in a cool, dry place, protected from light. Keep out of reach of children. Reconstituted solutions should be used immediately or stored according to manufacturer instructions.
Superpime Injection 1 gm/vial provides powerful, broad-spectrum antibacterial therapy, making it an essential option for treating severe and complicated bacterial infections under medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet